financetom
Business
financetom
/
Business
/
NRG Energy Tops Q3 Earnings, $3B Share Repurchase Program Extends Through 2028
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NRG Energy Tops Q3 Earnings, $3B Share Repurchase Program Extends Through 2028
Nov 6, 2025 10:14 AM

NRG Energy, Inc.'s ( NRG ) shares are declining on Thursday after the company reported third-quarter 2025 results.

• NRG shares are sliding on disappointing news. Review the technical setup here.

Details

NRG reported a revenue of $7.635 billion, beating the consensus of $7.482 billion, and sdjusted EPS stood at $2.78, beating the consensus of $2.10.

Quarterly operating income was at $414 million versus a loss of $812 million a year ago quarter.

Also Read: NRG Energy ( NRG ), CME Group, Bitmine Immersion Technologies And More On CNBC’s ‘Final Trades’

Adjusted EBITDA rose to $1.205 billion from $1.055 billion a year ago quarter. Adjusted net income rose to $537 million, up $434 million year-over-year, led by higher adjusted EBITDA.

Operating cash flow for the quarter was $484 million, compared to $31 million a year ago. Free Cash Flow Before Growth Investments was $828 million.

As of Sept. 30, 2025, NRG held around $0.7 billion in unrestricted cash and had $5.7 billion available through credit facilities, totaling $6.5 billion in liquidity.

Dividend & Share Repurchase

On Oct. 16, 2025, NRG's Board approved a $3 billion share repurchase program through 2028.

NRG announced on Oct. 20, 2025, a quarterly dividend of 44 cents per share ($1.76 annualized), payable on Nov. 17, 2025, to shareholders of record as of Nov. 3, 2025.

The company targets $1 billion repurchases in 2026, and an 8% increase to the annual dividend, raising it to $1.90 per share, in line with its 7%–9% long-term growth target.

As of Oct. 31, 2025, the company had returned $1.1 billion in buybacks and $258 million in dividends.

Outlook

NRG reaffirmed its 2025 capital allocation plan, aiming to return $1.3 billion via share repurchases and about $345 million in dividends.

NRG Energy ( NRG ) reiterated its outlook for adjusted EPS of $7.55-$8.15 (vs the consensus of $7.80), adjusted EBITDA of $3.875 billion- $4.025 billion, and Free Cash Flow Before Growth Investments at $2.100 billion- $2.250 billion.

For 2026, NRG projects adjusted EBITDA of $3.925 billion- $4.175 billion and Free Cash Flow Before Growth Investments of $1.975 billion – $2.225 billion.

NRG Price Action: NRG Energy shares are down 3.67% at $166.83 at publication on Thursday.

Read Next:

Billionaire David Tepper Won’t ‘Fight The Fed’—But He Hates This Market

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Janus Henderson to Acquire National Bank of Kuwait's Private Investments Team
--Janus Henderson to Acquire National Bank of Kuwait's Private Investments Team
May 2, 2024
08:43 AM EDT, 05/02/2024 (MT Newswires) -- Price: 31.63, Change: +0.47, Percent Change: +1.51 ...
Novartis to buy radiology drug specialist Mariana for $1 billion
Novartis to buy radiology drug specialist Mariana for $1 billion
May 2, 2024
May 2 (Reuters) - Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer said on Thursday. The deal includes up to $750 million of further payments upon achieving certain milestones, it added. Mariana Oncology is working on novel radioligand cancer therapies (RLTs) that...
Novo Nordisk Lifts Full-Year Sales Outlook as Obesity, Diabetes Drugs Drive First-Quarter Topline Beat
Novo Nordisk Lifts Full-Year Sales Outlook as Obesity, Diabetes Drugs Drive First-Quarter Topline Beat
May 2, 2024
08:39 AM EDT, 05/02/2024 (MT Newswires) -- Novo Nordisk ( NVO ) raised its full-year sales growth outlook on Thursday after the Danish drugmaker's topline topped Wall Street's expectations, buoyed by robust demand for its diabetes and obesity treatments. Sales are now anticipated to grow between 19% and 27% at constant exchange rates, compared with prior projections for an increase...
Church & Dwight's Q1 Adjusted Earnings, Net Sales Rise; 2024 Non-GAAP EPS Guidance Revised
Church & Dwight's Q1 Adjusted Earnings, Net Sales Rise; 2024 Non-GAAP EPS Guidance Revised
May 2, 2024
08:40 AM EDT, 05/02/2024 (MT Newswires) -- Church & Dwight ( CHD ) reported Q1 adjusted earnings Thursday of $0.96 per diluted share, up from $0.85 a year earlier. Analysts polled by Capital IQ expected $0.87. Net sales for the quarter ended March 31 were $1.50 billion, compared with $1.43 billion a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved